SCHEMBL10013752

SCHEMBL10013752

COc1ccc(C(=O)N(C)C)c(I)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.47
RAB9A P51151 1/20 0.47
HPGD P15428 4/20 0.46
ALDH1A1 P00352 4/20 0.46
CYP3A4 P08684 3/20 0.46
MAPK1 P28482 2/20 0.46
LMNA P02545 3/20 0.43
CYP1A2 P05177 3/20 0.43
CYP2C19 P33261 3/20 0.43
TSHR P16473 3/20 0.43
HSP90AA1 P07900 1/20 0.43
PDK1 Q15118 1/20 0.43
PDK2 Q15119 1/20 0.43
PDK3 Q15120 1/20 0.43
PDK4 Q16654 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
POLB P06746 1/20 0.42
PGR P06401 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15386350 0.81 HTT (0.55) NPC1RAB9AHPGDALDH1A1CYP3A4
SCHEMBL11653015 0.81 NPC1 (0.60) NPC1RAB9AHPGDALDH1A1CYP3A4
SCHEMBL3404282 0.80 SMN1; SMN2 (0.54) NPC1RAB9AHPGDALDH1A1CYP3A4
SCHEMBL154696 0.80 ALDH1A1 (0.65) NPC1RAB9AHPGDALDH1A1CYP3A4
SCHEMBL12442881 0.79 TSPO (0.43) NPC1RAB9AHPGDALDH1A1CYP3A4
SCHEMBL20060898 0.79 JAK2 (0.51) NPC1RAB9AHPGDALDH1A1CYP3A4
SCHEMBL1003506 0.79 CPS1 (0.58) NPC1RAB9AHPGDALDH1A1CYP3A4
SCHEMBL6931977 0.79 NPC1 (0.50) NPC1RAB9AHPGDALDH1A1CYP3A4
SCHEMBL4216899 0.79 KDM4E (0.56) NPC1RAB9AHPGDALDH1A1CYP3A4
SCHEMBL8235234 0.77 NPC1 (0.47) NPC1RAB9AHPGDALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8168833-B2 Schwartz reagents: methods of in situ generation and use QUEEN'S UNIVERSITY AT KINGSTON (CA) 2012-05-01 US disclosed
US-20100145060-A1 Schwartz Reagents: Methods of In Situ Generation and Use QUEEN'S UNIVERSITY AT KINGSTON (CA) 2010-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100145060-A1 Schwartz Reagents: Methods of In Situ Generation and Use CBR3, CBR1, ZFR NPC1 1362/4885RAB9A 4094/4885HPGD 3320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.